Endocannabinoids

S. J. Ward, R. F. Tuma

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

2 Scopus citations

Abstract

The endocannabinoid system is recognized as an important contributor to both homeostasis and pathological responses in the central nervous system (CNS). It is comprised of endogenously produced cannabinoid ligands, their receptors, and the enzymes responsible for their degradation. Included among the important homeostatic functions are regulation of synaptic transmission, metabolism and appetite, and pain processing. Alterations in endocannabinoid function can play both positive and negative roles under pathological conditions, influencing metabolism and appetite, pain, and inflammation. Modulation of endocannabinoid function has become an important therapeutic target for these areas, with both naturally occurring and synthetic ligands being investigated in the clinic as well as in animal models. In addition, endocannabinoid modulation may also be an important therapeutic strategy for other CNS disorders, including mood disorders and substance abuse.

Original languageEnglish
Title of host publicationEncyclopedia of the Neurological Sciences
PublisherElsevier Inc.
Pages42-47
Number of pages6
ISBN (Electronic)9780123851574
ISBN (Print)9780123851581
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Keywords

  • 2-Arachidonyl glycerol
  • Arachidonylethanolamide (anandamine)
  • Cannabinoid 1 receptor
  • Cannabinoid 2 receptor
  • Endocannabinoid
  • Excitotoxic injury
  • Fatty acid amide hydrolase
  • Inflammation
  • Metabolism
  • Monoacylglycerol lipase
  • Mood disorders
  • Neuroprotection
  • Pain
  • Stroke

Fingerprint

Dive into the research topics of 'Endocannabinoids'. Together they form a unique fingerprint.

Cite this